Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Single Anastomosis Sleeve Jejunal Bypass Compared to Mini Gastric Bypass and Sleeve Gastrectomy as a Treatment for Morbid Obesity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03821688
Recruitment Status : Completed
First Posted : January 30, 2019
Last Update Posted : March 17, 2020
Sponsor:
Information provided by (Responsible Party):
Alaa Mstafa Hassan Sewefy, Minia University

Brief Summary:
150 morbidly obese patients divided into to equal groups, group A underwent single anastomosis sleeve jejunal bypass with biliary limb length of 200 cm from the duodenal-jejunal flexure and group B underwent mini gastric bypass, group C underwent sleeve gastrectomy. All patients were followed for at least one year. all cases were evaluated as regard BMI, complications, nutritional status and obesity-related comorbidities.

Condition or disease Intervention/treatment Phase
Morbid Obesity Procedure: SAS-JB Procedure: MBG Procedure: LSG Not Applicable

Detailed Description:
150 morbidly obese patients divided into to equal groups, group A underwent single anastomosis sleeve jejunal bypass with biliary limb length of 200 cm from the duodenal-jejunal flexure and group B underwent mini gastric bypass, group C underwent sleeve gastrectomy. All patients were followed for at least one year. all cases were evaluated as regard BMI, complications, nutritional status and obesity-related comorbidities.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 210 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Single Anastomosis Sleeve Jejunal Bypass
Actual Study Start Date : May 15, 2016
Actual Primary Completion Date : August 10, 2018
Actual Study Completion Date : August 10, 2018

Arm Intervention/treatment
Experimental: SAS-JB
laparoscopic single anastomosis sleeve jejunal bypass
Procedure: SAS-JB
Active Comparator: MGB
laparoscopic mini gastric bypass
Procedure: MBG
Active Comparator: LSG
laparoscopic sleeve gastrectomy
Procedure: LSG



Primary Outcome Measures :
  1. percentage of excess weight loss [ Time Frame: 12 months ]
    percentage of excess weight loss in kilogram


Secondary Outcome Measures :
  1. the incidence of nutritional deficiency [ Time Frame: 2 years ]
    the incidence of nutritional deficiency like anemia, hypocalcamia, hypoproteinemia.

  2. the rate of improved co morbidity [ Time Frame: 2 years ]
    the effect of the operation on co morbidity like diabetes and hypertension

  3. the incidence of early operative complications [ Time Frame: one month ]
    early operative complications like leak, bleeding



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • obese patients with BMI more than 40 with or without co-morbidity or more than 35 with co-morbidity
  • patients fit for laparoscopic surgery
  • give approval to share in the study

Exclusion Criteria:

  • patients refused to share in the study
  • patients unfit for surgery
  • patients aged less than 18 and older than 60
  • patient with previous upper abdominal surgery either for obesity or other diseases
  • revisional bariatric procedures

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03821688


Locations
Layout table for location information
Egypt
Faculty of medicine
Minya, Egypt, 61511
Sponsors and Collaborators
Minia University
Investigators
Layout table for investigator information
Principal Investigator: Alaa M Sewefy, MD Minia University
Layout table for additonal information
Responsible Party: Alaa Mstafa Hassan Sewefy, Assistant professor, Minia University
ClinicalTrials.gov Identifier: NCT03821688    
Other Study ID Numbers: fac.med.047
First Posted: January 30, 2019    Key Record Dates
Last Update Posted: March 17, 2020
Last Verified: March 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Obesity
Obesity, Morbid
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms